Non-participation of asymptomatic candidates in screening protocols reduces early diagnosis and worsens prognosis of colorectal cancer

doi:10.3748/wjg.v30.i26.3198

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (83)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=62

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=13

Jul 14, 2024 (publication date) through Jul 10, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Jul 14, 2024; 30(26): 3198-3200
Published online Jul 14, 2024. doi: 10.3748/wjg.v30.i26.3198

Non-participation of asymptomatic candidates in screening protocols reduces early diagnosis and worsens prognosis of colorectal cancer

Sergio Pérez-Holanda

Sergio Pérez-Holanda, Office of Regional Viceministry of Health, Regional Viceministry of Health, Oviedo 33005, Asturias, Spain

Author contributions: Pérez-Holanda S write and revise the paper.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Sergio Pérez-Holanda, MD, MSc, PhD, Doctor, Senior Scientist, Surgeon, Surgical Oncologist, Office of Regional Viceministry of Health, Regional Viceministry of Health, C Arturo Álvarez Buylla, Oviedo 33005, Asturias, Spain. perezholandas@gmail.com

Received: March 14, 2024
Revised: May 31, 2024
Accepted: June 18, 2024
Published online: July 14, 2024
Processing time: 117 Days and 1.1 Hours

Core Tip

Core Tip: Agatsuma et al’s study used cancer registries from two Japanese hospitals to identify the subgroups that benefit most from screening programs, and clarified the stage at diagnosis in three groups of colorectal cancer (CRC) patients: CRC screening, follow-up (patients detected during follow-up for other comorbidities), and CRC symptomatic. The proportion of early-stage diagnoses was higher in the follow-up group than in the symptomatic group and was comparable to that in the cancer screening group. Therefore, CRC screening should be recommended, especially in patients without regular hospital visits for comorbidities, to improve population participation.